v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Common Stock
Restricted Stock
Additional Paid-In Capital
Additional Paid-In Capital
At The Market Offering
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance of the period (in shares) at Dec. 31, 2024     137,706,596            
Balance as of beginning of the period at Dec. 31, 2024 $ 250,857   $ 14     $ 383,739   $ (135,109) $ 2,213
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)     318,921            
Exercise of stock options $ 720         720      
Issuance of common stock (in shares) 318,921       134,832        
Issuance of common stock in at-the-market offering, net of offering costs $ 720                
Issuance of stock in connection with acquisition of business (in shares)     820,840   274,339        
Issuance of common stock in connection with acquisition of business $ 27,408         27,408      
Common stock withheld for taxes (in shares) (66,724)   (66,724)            
Common stock withheld for taxes $ (1,595)         (1,595)      
Stock-based compensation 2,311         2,311      
Change in unrealized loss on marketable debt securities (561)               (561)
Net loss (9,810)             (9,810)  
Ending balance of the period (in shares) at Mar. 31, 2025     139,188,804            
Balance as of end of the period at Mar. 31, 2025 $ 269,330   $ 14     412,583   (144,919) 1,652
Beginning balance of the period (in shares) at Dec. 31, 2025 160,514,103   160,514,103            
Balance as of beginning of the period at Dec. 31, 2025 $ 1,476,210   $ 16     1,715,787   (240,772) 1,179
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Exercise of stock options (in shares)     290,908            
Exercise of stock options $ 737         737      
Issuance of common stock (in shares) 290,908     12,376,352 687,756        
Issuance of common stock in at-the-market offering, net of offering costs $ 737 $ 1,181,897   $ 1     $ 1,181,896    
Common stock withheld for taxes (in shares) (1,280)   (1,280)            
Common stock withheld for taxes $ (75)         (75)      
Stock-based compensation 15,586         15,586      
Change in unrealized loss on marketable debt securities (2,661)               (2,661)
Net loss $ (33,065)             (33,065)  
Ending balance of the period (in shares) at Mar. 31, 2026 173,867,839   173,867,839            
Balance as of end of the period at Mar. 31, 2026 $ 2,638,629   $ 17     $ 2,913,931   $ (273,837) $ (1,482)